A Tat Fusion Protein–Based Tumor Vaccine for Breast Cancer

被引：0
|
作者：
Carsten T. Viehl
Michelle Becker-Hapak
Jason S. Lewis
Yoshiyuki Tanaka
Udaya K. Liyanage
David C. Linehan
Timothy J. Eberlein
Peter S. Goedegebuure
机构：
[1] Washington University School of Medicine,Department of Surgery
[2] University of Basel,Department of Surgery, Divisions of General Surgery and Surgical Research
[3] Alvin J. Siteman Cancer Center,Division of Oncology
[4] Washington University School of Medicine,Mallinckrodt Institute of Radiology
[5] Washington University School of Medicine,Alvin J. Siteman Cancer Center
[6] Washington University School of Medicine,undefined
来源：
Annals of Surgical Oncology | 2005年 / 12卷
关键词：
Tat fusion protein; Her2/; Cancer vaccine; Breast cancer; Animal study;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：517 / 525
页数：8
相关论文
共 50 条
  • [41] Boosting Tat DNA vaccine with Tat protein stimulates strong cellular and humoral immune responses in mice
    Alipour, Samira
    Mahdavi, Atiyeh
    BIOTECHNOLOGY LETTERS, 2020, 42 (04) : 505 - 517
  • [42] Combination of OX40L fusion protein with an anti-tumor vaccine reduces lung metastasis and prolongs survival in a murine model of metastatic triple negative breast cancer
    Malamas, Anthony S.
    Hammond, Scott A.
    Schlom, Jeffrey
    Hodge, James W.
    CANCER RESEARCH, 2017, 77
  • [43] Injectable hydrogel-based tumor vaccine with fibrotic tumor immune microenvironment remodeling to prevent breast cancer postoperative recurrence and metastases
    Sun, Honghao
    Zhao, Huimin
    Yin, Ronghui
    Zhou, Chenxi
    Wu, Ming
    Deng, Yueyang
    Zhou, Zhanwei
    Sun, Minjie
    CHINESE CHEMICAL LETTERS, 2025, 36 (05)
  • [44] Dissecting tumor antigens and immune subtypes for mRNA vaccine development in breast cancer
    Li, Lang
    He, Lvyuan
    Zhu, Ying
    JOURNAL OF BIG DATA, 2023, 10 (01)
  • [45] Fabrication and Characterization of Tumor Nano-Lysate as a Preventative Vaccine for Breast Cancer
    Dombroski, Jenna A.
    Jyotsana, Nidhi
    Crews, Davis W.
    Zhang, Zhenjiang
    King, Michael R.
    LANGMUIR, 2020, 36 (23) : 6531 - 6539
  • [46] Identification of tumor antigens and immune subtypes in breast cancer for mRNA vaccine development
    Li, Ruo Qi
    Wang, Wei
    Yan, Lei
    Song, Li Ying
    Guan, Xin
    Zhang, Wei
    Lian, Jing
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [47] Dissecting tumor antigens and immune subtypes for mRNA vaccine development in breast cancer
    Lang Li
    Lvyuan He
    Ying Zhu
    Journal of Big Data, 10
  • [48] Superior efficacy of dendritic cell-tumor fusion vaccine compared with tumor lysate-pulsed dendritic cell vaccine in colon cancer
    Kao, JY
    Zhang, M
    Chen, CM
    Chen, JJ
    IMMUNOLOGY LETTERS, 2005, 101 (02) : 154 - 159
  • [49] Protein-based nanoparticles in cancer vaccine development
    Neek, Medea
    Kim, Tae Il
    Wang, Szu-Wen
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2019, 15 (01) : 164 - 174
  • [50] An adenoviral vector cancer vaccine that delivers a tumor-associated antigen/CD40-ligand fusion protein to dendritic cells
    Zhang, LX
    Tang, YC
    Akbulut, H
    Zelterman, D
    Linton, PJ
    Deisseroth, AB
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (25) : 15101 - 15106
12345